Monarch Partners Asset Management’s Krystal Biotech KRYS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	$4.27M	Buy	53,905 +7,411	+16%	+$587K	1.26%	15
2022 Q3	$3.24M	Buy	46,494 +31,719	+215%	+$2.21M	0.97%	28
2022 Q2	$970K	Buy	+14,775	New	+$970K	0.27%	131